→
As of the latest data, ARKG is priced at $34.88, reflecting a decrease of $0.22 (-0.63%) from the previous close of $35.10. The ETF has a 52-week high of $37.28 and a low of $22.95, indicating significant price volatility over the past year. The day range for ARKG was between $34.85 and $36.
Investors may consider the price movements and volatility of ARKG when evaluating their positions.
Some investors point to the 52-week high of $37.28 as a potential sign of recovery if market conditions improve, suggesting a strong interest in genomic technologies. Additionally, the ETF's focus on innovative biotech companies aligns with ongoing advancements in the healthcare sector.
Conversely, the decline to a price of $34.88 from its previous close indicates ongoing market pressure, with a year-to-date performance potentially affected by broader market trends. The significant gap between the 52-week high and low suggests substantial volatility, raising concerns among risk-averse investors.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
As of the latest data, ARKG is priced at $34.88, reflecting a decrease of $0.22 (-0.63%) from the previous close of $35.10. The ETF has a 52-week high of $37.28 and a low of $22.95, indicating significant price volatility over the past year. The day range for ARKG was between $34.85 and $36.
Conversely, the decline to a price of $34.88 from its previous close indicates ongoing market pressure, with a year-to-date performance potentially affected by broader market trends. The significant gap between the 52-week high and low suggests substantial volatility, raising concerns among risk-averse investors.
Some investors point to the 52-week high of $37.28 as a potential sign of recovery if market conditions improve, suggesting a strong interest in genomic technologies. Additionally, the ETF's focus on innovative biotech companies aligns with ongoing advancements in the healthcare sector.
Some investors point to the 52-week high of $37.28 as a potential sign of recovery if market conditions improve, suggesting a strong interest in genomic technologies. Additionally, the ETF's focus on innovative biotech companies aligns with ongoing advancements in the healthcare sector. Conversely, the decline to a price of $34.88 from its previous close indicates ongoing market pressure, with a year-to-date performance potentially affected by broader market trends. The significant gap between the 52-week high and low suggests substantial volatility, raising concerns among risk-averse investors.
As of the latest data, ARKG is priced at $34.88, reflecting a decrease of $0.22 (-0.63%) from the previous close of $35.10. The ETF has a 52-week high of $37.28 and a low of $22.95, indicating significant price volatility over the past year. The day range for ARKG was between $34.85 and $36.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.
Helm Terminal offers free AI-powered stock analysis for ARKG at helmterminal.dev/analyze/ARKG, updated continuously during US market hours. No signup required.